Np mrd loader

Record Information
Version2.0
Created at2022-09-12 01:36:53 UTC
Updated at2022-09-12 01:36:53 UTC
NP-MRD IDNP0322692
Secondary Accession NumbersNone
Natural Product Identification
Common Name2-[(2-{[2-(3-amino-2-hydroxy-n-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid
Description2-[(2-{[2-(3-Amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. It was first documented in 2002 (PMID: 31593387). Based on a literature review a significant number of articles have been published on 2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid (PMID: 27253005) (PMID: 27583328) (PMID: 36127157) (PMID: 36127156).
Structure
Thumb
Synonyms
ValueSource
2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoateGenerator
2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulphinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoateGenerator
2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulphinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acidGenerator
Chemical FormulaC35H52N4O9S
Average Mass704.8800 Da
Monoisotopic Mass704.34550 Da
IUPAC Name2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid
Traditional Name2-[(2-{[2-(3-amino-2-hydroxy-N-methyldecanamido)-1-hydroxy-4-methanesulfinylbutylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-methoxyphenyl)propanoic acid
CAS Registry NumberNot Available
SMILES
CCCCCCCC(N)C(O)C(=O)N(C)C(CC[S+](C)[O-])C(O)=NC(CC1=CC=C(O)C=C1)C(O)=NC(CC1=CC=C(OC)C=C1)C(O)=O
InChI Identifier
InChI=1S/C35H52N4O9S/c1-5-6-7-8-9-10-27(36)31(41)34(44)39(2)30(19-20-49(4)47)33(43)37-28(21-23-11-15-25(40)16-12-23)32(42)38-29(35(45)46)22-24-13-17-26(48-3)18-14-24/h11-18,27-31,40-41H,5-10,19-22,36H2,1-4H3,(H,37,43)(H,38,42)(H,45,46)
InChI KeyIQSISHQRPPTNJD-UHFFFAOYSA-N
Experimental Spectra
Not Available
Predicted Spectra
Not Available
Chemical Shift Submissions
Not Available
Species
Species of OriginNot Available
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassPeptidomimetics
Sub ClassHybrid peptides
Direct ParentHybrid peptides
Alternative Parents
Substituents
  • Hybrid peptide
  • Tyrosine or derivatives
  • Phenylalanine or derivatives
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-alpha-amino acid
  • Alpha-amino acid amide
  • 3-phenylpropanoic-acid
  • Beta amino acid or derivatives
  • Amphetamine or derivatives
  • Alpha-amino acid or derivatives
  • N-substituted-alpha-amino acid
  • Phenoxy compound
  • Methoxybenzene
  • Phenol ether
  • Anisole
  • 1-hydroxy-2-unsubstituted benzenoid
  • Phenol
  • Alkyl aryl ether
  • Fatty acyl
  • Benzenoid
  • N-acyl-amine
  • Monosaccharide
  • Fatty amide
  • Monocyclic benzene moiety
  • Tertiary carboxylic acid amide
  • Amino acid
  • Sulfoxide
  • Secondary carboxylic acid amide
  • Secondary alcohol
  • Carboxamide group
  • Amino acid or derivatives
  • Sulfinyl compound
  • Monocarboxylic acid or derivatives
  • Ether
  • Carboxylic acid
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Primary amine
  • Organosulfur compound
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Carbonyl group
  • Amine
  • Alcohol
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Physical Properties
StateNot Available
Experimental Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties
PropertyValueSource
logP0.35ChemAxon
pKa (Strongest Acidic)3.08ChemAxon
pKa (Strongest Basic)8.53ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count12ChemAxon
Hydrogen Donor Count6ChemAxon
Polar Surface Area215.57 ŲChemAxon
Rotatable Bond Count22ChemAxon
Refractivity188.35 m³·mol⁻¹ChemAxon
Polarizability76.59 ųChemAxon
Number of Rings2ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
HMDB IDNot Available
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FoodDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound162815729
PDB IDNot Available
ChEBI IDNot Available
Good Scents IDNot Available
References
General References
  1. Authors unspecified: Childhood Vascular Tumors Treatment (PDQ(R)): Patient Version. 2002. [PubMed:27253005 ]
  2. Authors unspecified: Childhood Esophageal Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:31593387 ]
  3. Authors unspecified: Financial Toxicity and Cancer Treatment (PDQ(R)): Health Professional Version. 2002. [PubMed:27583328 ]
  4. Gadot R, Najera R, Hirani S, Anand A, Storch E, Goodman WK, Shofty B, Sheth SA: Efficacy of deep brain stimulation for treatment-resistant obsessive-compulsive disorder: systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2022 Sep 20. pii: jnnp-2021-328738. doi: 10.1136/jnnp-2021-328738. [PubMed:36127157 ]
  5. Koggel LM, Lantinga MA, Buchner FL, Drenth JPH, Frankema JS, Heeregrave EJ, Heringa M, Numans ME, Siersema PD: Predictors for inappropriate proton pump inhibitor use: observational study in primary care. Br J Gen Pract. 2022 Jun 24. pii: BJGP.2022.0178. doi: 10.3399/BJGP.2022.0178. [PubMed:36127156 ]
  6. LOTUS database [Link]